mRNA Vaccines & Therapeutics Market Report

Europe mRNA Vaccines & Therapeutics Market Size, Status and Forecast 2014-2026

  • POSTDATE：May 29, 2020
  • PAGES：135
  • REPORT CODE：GMM533374
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The mRNA Vaccines & Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe mRNA Vaccines & Therapeutics Market Segmentations:

    By Player:

    • CureVac

    • eTheRNA immunotherapies

    • Kernal Biologics

    • AstraZeneca

    • In-Cell-Art

    • RaNa Therapeutics

    • Bayer

    • Boehringer Ingelheim

    • Moderna Therapeutics

    • Argos Therapeutics

    • Intellia Therapeutics

    • MaxCyte

    • CRISPR Therapeutics

    • Ethris

    • GlaxoSmithKline Vaccines

    • Novartis

    • Precision NanoSystems

    • PhaseRx

    • BioNTech

    • Janssen

    By Type:

    • Standardization Of Cancer Treatment MRNA Vaccine

    • Individualized Cancer Treatment MRNA Vaccine

    • Infectious Disease Treatment MRNA Vaccine

    • Infection Prevention MRNA Vaccine

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccines & Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine from 2014 to 2026

    • 1.3.2 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026

    • 1.3.3 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026

    • 1.3.4 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.3 Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of mRNA Vaccines & Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of mRNA Vaccines & Therapeutics by Major Types

      • 3.4.1 Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine

      • 3.4.2 Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine

      • 3.4.3 Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine

      • 3.4.4 Market Size and Growth Rate of Infection Prevention MRNA Vaccine

    4 Segmentation of mRNA Vaccines & Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of mRNA Vaccines & Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hospital for Construction

      • 4.4.2 Market Size and Growth Rate of Clinic for Construction

      • 4.4.3 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe mRNA Vaccines & Therapeutics Production Analysis by Top Regions

    • 5.2 Europe mRNA Vaccines & Therapeutics Consumption Analysis by Top Regions

    • 5.3 Europe mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.2 UK mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 France mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Circulation of mRNA Vaccines & Therapeutics Market among Top Countries

    • 6.1 Top 5 Export Countries in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany mRNA Vaccines & Therapeutics Landscape Analysis

    • 7.1 Germany mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 7.2 Germany mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    8. UK mRNA Vaccines & Therapeutics Landscape Analysis

    • 8.1 UK mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 8.2 UK mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    9. France mRNA Vaccines & Therapeutics Landscape Analysis

    • 9.1 France mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 9.2 France mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    10. Italy mRNA Vaccines & Therapeutics Landscape Analysis

    • 10.1 Italy mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 10.2 Italy mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    11. Spain mRNA Vaccines & Therapeutics Landscape Analysis

    • 11.1 Spain mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 11.2 Spain mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    12. Poland mRNA Vaccines & Therapeutics Landscape Analysis

    • 12.1 Poland mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 12.2 Poland mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    13. Russia mRNA Vaccines & Therapeutics Landscape Analysis

    • 13.1 Russia mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 13.2 Russia mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    14. Switzerland mRNA Vaccines & Therapeutics Landscape Analysis

    • 14.1 Switzerland mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 14.2 Switzerland mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    15. Turkey mRNA Vaccines & Therapeutics Landscape Analysis

    • 15.1 Turkey mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 15.2 Turkey mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 16.3.1 Denmark mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 16.3.2 Finland mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 16.3.3 Norway mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 16.3.4 Sweden mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 16.3.6 Iceland mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 17.3.1 Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 17.3.2 Netherlands mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 17.3.3 Luxembourg mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Landscape Analysis by Top Countries

      • 18.3.1 Estonia mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 18.3.2 Latvia mRNA Vaccines & Therapeutics Market Volume and Growth Rate

      • 18.3.3 Lithuania mRNA Vaccines & Therapeutics Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 CureVac

      • 19.1.1 CureVac Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 eTheRNA immunotherapies

      • 19.2.1 eTheRNA immunotherapies Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Kernal Biologics

      • 19.3.1 Kernal Biologics Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 AstraZeneca

      • 19.4.1 AstraZeneca Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 In-Cell-Art

      • 19.5.1 In-Cell-Art Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 RaNa Therapeutics

      • 19.6.1 RaNa Therapeutics Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Bayer

      • 19.7.1 Bayer Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Boehringer Ingelheim

      • 19.8.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Moderna Therapeutics

      • 19.9.1 Moderna Therapeutics Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Argos Therapeutics

      • 19.10.1 Argos Therapeutics Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Intellia Therapeutics

      • 19.11.1 Intellia Therapeutics Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 MaxCyte

      • 19.12.1 MaxCyte Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 CRISPR Therapeutics

      • 19.13.1 CRISPR Therapeutics Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Ethris

      • 19.14.1 Ethris Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 GlaxoSmithKline Vaccines

      • 19.15.1 GlaxoSmithKline Vaccines Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Novartis

      • 19.16.1 Novartis Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Precision NanoSystems

      • 19.17.1 Precision NanoSystems Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 PhaseRx

      • 19.18.1 PhaseRx Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 BioNTech

      • 19.19.1 BioNTech Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Janssen

      • 19.20.1 Janssen Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    The List of Tables and Figures (Totals 113 Figures and 209 Tables)

    • Figure Product Picture

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine Market, 2015 - 2026 (USD Million)

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine Market, 2015 - 2026 (USD Million)

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine Market, 2015 - 2026 (USD Million)

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine Market, 2015 - 2026 (USD Million)

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure UK mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure France mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Finland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Norway mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania mRNA Vaccines & Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of mRNA Vaccines & Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of mRNA Vaccines & Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of mRNA Vaccines & Therapeutics by Different Types from 2014 to 2026

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment MRNA Vaccine Market, 2015 - 2026 (USD Million)

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine Market, 2015 - 2026 (USD Million)

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine Market, 2015 - 2026 (USD Million)

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Infection Prevention MRNA Vaccine Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of mRNA Vaccines & Therapeutics by Different End-Users from 2014 to 2026

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure mRNA Vaccines & Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe mRNA Vaccines & Therapeutics Production by Major Regions

    • Table Europe mRNA Vaccines & Therapeutics Production Share by Major Regions

    • Figure Europe mRNA Vaccines & Therapeutics Production Share by Major Countries and Regions in 2014

    • Table Europe mRNA Vaccines & Therapeutics Consumption by Major Regions

    • Table Europe mRNA Vaccines & Therapeutics Consumption Share by Major Regions

    • Table Germany mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table UK mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table France mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Italy mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Spain mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Poland mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Russia mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Switzerland mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Turkey mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in mRNA Vaccines & Therapeutics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Germany mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Germany mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Germany mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table UK mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table UK mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table UK mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table UK mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table France mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table France mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table France mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table France mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Italy mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Italy mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Italy mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Italy mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Spain mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Spain mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Spain mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Spain mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Poland mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Poland mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Poland mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Poland mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Russia mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Russia mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Russia mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Russia mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Switzerland mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Switzerland mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Switzerland mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Turkey mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Turkey mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Turkey mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Turkey mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) mRNA Vaccines & Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries mRNA Vaccines & Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table CureVac Profiles

    • Table CureVac Production, Value, Price, Gross Margin 2014-2019

    • Table CureVac Product benchmarking

    • Table CureVac Strategic initiatives

    • Table CureVac SWOT analysis

    • Table eTheRNA immunotherapies Profiles

    • Table eTheRNA immunotherapies Production, Value, Price, Gross Margin 2014-2019

    • Table eTheRNA immunotherapies Product benchmarking

    • Table eTheRNA immunotherapies Strategic initiatives

    • Table eTheRNA immunotherapies SWOT analysis

    • Table Kernal Biologics Profiles

    • Table Kernal Biologics Production, Value, Price, Gross Margin 2014-2019

    • Table Kernal Biologics Product benchmarking

    • Table Kernal Biologics Strategic initiatives

    • Table Kernal Biologics SWOT analysis

    • Table AstraZeneca Profiles

    • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

    • Table AstraZeneca Product benchmarking

    • Table AstraZeneca Strategic initiatives

    • Table AstraZeneca SWOT analysis

    • Table In-Cell-Art Profiles

    • Table In-Cell-Art Production, Value, Price, Gross Margin 2014-2019

    • Table In-Cell-Art Product benchmarking

    • Table In-Cell-Art Strategic initiatives

    • Table In-Cell-Art SWOT analysis

    • Table RaNa Therapeutics Profiles

    • Table RaNa Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table RaNa Therapeutics Product benchmarking

    • Table RaNa Therapeutics Strategic initiatives

    • Table RaNa Therapeutics SWOT analysis

    • Table Bayer Profiles

    • Table Bayer Production, Value, Price, Gross Margin 2014-2019

    • Table Bayer Product benchmarking

    • Table Bayer Strategic initiatives

    • Table Bayer SWOT analysis

    • Table Boehringer Ingelheim Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Boehringer Ingelheim Product benchmarking

    • Table Boehringer Ingelheim Strategic initiatives

    • Table Boehringer Ingelheim SWOT analysis

    • Table Moderna Therapeutics Profiles

    • Table Moderna Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Moderna Therapeutics Product benchmarking

    • Table Moderna Therapeutics Strategic initiatives

    • Table Moderna Therapeutics SWOT analysis

    • Table Argos Therapeutics Profiles

    • Table Argos Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Argos Therapeutics Product benchmarking

    • Table Argos Therapeutics Strategic initiatives

    • Table Argos Therapeutics SWOT analysis

    • Table Intellia Therapeutics Profiles

    • Table Intellia Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Intellia Therapeutics Product benchmarking

    • Table Intellia Therapeutics Strategic initiatives

    • Table Intellia Therapeutics SWOT analysis

    • Table MaxCyte Profiles

    • Table MaxCyte Production, Value, Price, Gross Margin 2014-2019

    • Table MaxCyte Product benchmarking

    • Table MaxCyte Strategic initiatives

    • Table MaxCyte SWOT analysis

    • Table CRISPR Therapeutics Profiles

    • Table CRISPR Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table CRISPR Therapeutics Product benchmarking

    • Table CRISPR Therapeutics Strategic initiatives

    • Table CRISPR Therapeutics SWOT analysis

    • Table Ethris Profiles

    • Table Ethris Production, Value, Price, Gross Margin 2014-2019

    • Table Ethris Product benchmarking

    • Table Ethris Strategic initiatives

    • Table Ethris SWOT analysis

    • Table GlaxoSmithKline Vaccines Profiles

    • Table GlaxoSmithKline Vaccines Production, Value, Price, Gross Margin 2014-2019

    • Table GlaxoSmithKline Vaccines Product benchmarking

    • Table GlaxoSmithKline Vaccines Strategic initiatives

    • Table GlaxoSmithKline Vaccines SWOT analysis

    • Table Novartis Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis Product benchmarking

    • Table Novartis Strategic initiatives

    • Table Novartis SWOT analysis

    • Table Precision NanoSystems Profiles

    • Table Precision NanoSystems Production, Value, Price, Gross Margin 2014-2019

    • Table Precision NanoSystems Product benchmarking

    • Table Precision NanoSystems Strategic initiatives

    • Table Precision NanoSystems SWOT analysis

    • Table PhaseRx Profiles

    • Table PhaseRx Production, Value, Price, Gross Margin 2014-2019

    • Table PhaseRx Product benchmarking

    • Table PhaseRx Strategic initiatives

    • Table PhaseRx SWOT analysis

    • Table BioNTech Profiles

    • Table BioNTech Production, Value, Price, Gross Margin 2014-2019

    • Table BioNTech Product benchmarking

    • Table BioNTech Strategic initiatives

    • Table BioNTech SWOT analysis

    • Table Janssen Profiles

    • Table Janssen Production, Value, Price, Gross Margin 2014-2019

    • Table Janssen Product benchmarking

    • Table Janssen Strategic initiatives

    • Table Janssen SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US